Results 41 to 50 of about 46,054 (219)

Silent Danger: Coexistence of Late‐Onset External Iliac Artery Pseudoaneurysm and Deep Vein Thrombosis

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Pseudoaneurysm (PA) is a well‐known vascular complication following percutaneous interventions, typically occurring in the early post‐procedural period. However, delayed‐onset PA associated with deep vein thrombosis (DVT) is an uncommon presentation.
Sefa Tatar   +3 more
wiley   +1 more source

Viabahn for femoropopliteal in-stent restenosis

open access: yesAnnals of Saudi Medicine, 2012
In-stent restenosis in the femoropopliteal artery is common (20%-40%). Treatment of in-stent restenosis is challenged by poor patency rate. An ePTFE-covered stent-graft (Viabahn) is inert with a very small pore size that does not allow for significant tissue in-growth.
Jaime Ghitelman   +3 more
openaire   +4 more sources

Drug Coated Balloons Versus Drug‐Eluting Stents in Patients With De Novo Coronary Artery Disease

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background In patients with de novo coronary artery disease (CAD), percutaneous coronary intervention (PCI) with drug eluting stent (DES) implantation is the gold standard therapy. New evidence is available with drug coated balloons (DCB) angioplasty. The objective of this meta‐analysis was to compare the efficacy and safety of DCB angioplasty
Daniel O'Callaghan   +9 more
wiley   +1 more source

Results of Coronary Stenting for Restenosis

open access: yesJournal of the American College of Cardiology, 1996
This study attempted to analyze immediate and long-term angiographic and clinical results of coronary stent implantation for restenosis in a consecutive group of patients.The rate of stent utilization in patients with coronary artery disease has increased exponentially in recent years.
Akira Itoh   +5 more
openaire   +3 more sources

Perfil dos pacientes submetidos à angioplastia trasluminal coronariana com stents farmacológicos no Instituto de Cardiologia de Santa Catarina. [PDF]

open access: yes, 2007
Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina. Curso de Medicina.
Aquino, Vivian Wuerges de
core  

Multifunctional star-shaped polylactic acid implants for use in angioplasty [PDF]

open access: yes, 2014
Star-shaped polylactic acids with different tacticity were synthesized and both polymers are capable of bestowing properties of anticoagulation and angiogenesis to their living host.
Kiran, M. S.   +3 more
core   +2 more sources

The Predictive Value of Quantitative Flow Ratio and Its Derived Angiographic Microvascular Resistance for Restenosis Following Drug‐Coated Balloon Angioplasty

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Initially, drug‐coated balloon (DCB) angioplasty was primarily employed for in‐stent restenosis (ISR) treatment. Over time, its indications have broadened to include de novo small‐vessel lesions and bifurcation lesions. However, there is a lack of effective strategies to reduce restenosis rates post‐DCB angioplasty.
Chenhang Wang, Li Chen, Xiaoyong Xu
wiley   +1 more source

Introductory editorial: drug-eluting stents or drug-eluting grafts? Insights from proteomic analysis [PDF]

open access: yes, 2017
No abstract ...
Al-Attar, Nawwar   +5 more
core   +1 more source

Impact of Femoropopliteal Drug‐Coated Balloon Use on Clinical Outcomes in Patients With Chronic Limb‐Threatening Ischemia

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Drug‐coated balloons (DCBs) for femoropopliteal (FP) lesions have demonstrated superiority over standard percutaneous transluminal angioplasty (PTA) in maintaining vessel patency. However, data on whether the good durability of DCBs translates into improved wound outcome in chronic limb‐threatening ischemia (CLTI) patients are ...
Haruya Yamane   +11 more
wiley   +1 more source

Hypersensitivity and in-stent restenosis in coronary stent materials

open access: yesFrontiers in Bioengineering and Biotechnology, 2022
Coronary heart disease (CHD) is a type of cardiovascular disease with the highest mortality rate worldwide. Percutaneous transluminal coronary intervention (PCI) is the most effective method for treating CHD. However, in-stent restenosis (ISR), a long-term complication after PCI, affects the prognosis of patients with CHD.
Wansong Hu, Jun Jiang
openaire   +3 more sources

Home - About - Disclaimer - Privacy